Maximum diversity weighting for biomarkers with application in HIV-1 vaccine studies.


Journal

Statistics in medicine
ISSN: 1097-0258
Titre abrégé: Stat Med
Pays: England
ID NLM: 8215016

Informations de publication

Date de publication:
10 09 2019
Historique:
received: 11 05 2018
revised: 15 02 2019
accepted: 08 05 2019
pubmed: 20 6 2019
medline: 18 12 2020
entrez: 20 6 2019
Statut: ppublish

Résumé

While studying the association between risk of HIV-1 infection and vaccine-elicited immune responses in preventative HIV-1 vaccine recipients, we encountered a need to combine a collection of biomarkers in an unsupervised fashion with the goal of preserving signal diversity within that collection. Inspired by methods for weighting protein sequences from the biological sequence analysis literature, we propose novel methods for weighting biomarkers, which we call maximum diversity weights. These weights are defined as the weights that maximize measures of signal diversity within a collection of biomarkers. While the optimization problems do not admit analytical solutions, they are convex and hence can be solved efficiently using iterative search algorithms. Through Monte Carlo studies and a real data example from HIV-1 vaccine research, we show that using maximum diversity weights in association studies can lead to an increase in power over other commonly used weights such as uniform weights or principal component-based weights.

Identifiants

pubmed: 31215662
doi: 10.1002/sim.8212
pmc: PMC6684395
mid: NIHMS1041471
doi:

Substances chimiques

AIDS Vaccines 0
Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

3936-3946

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI122991
Pays : United States
Organisme : NIH HHS
ID : S10 OD020069
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI068635
Pays : United States

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Références

N Engl J Med. 2009 Dec 3;361(23):2209-20
pubmed: 19843557
J Mol Biol. 1990 Dec 20;216(4):813-8
pubmed: 2176240
Clin Infect Dis. 2012 Jun;54(11):1615-7
pubmed: 22437237
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Proc Natl Acad Sci U S A. 2013 May 28;110(22):9019-24
pubmed: 23661056
J Comput Biol. 1995 Spring;2(1):9-23
pubmed: 7497123
Proc Int Conf Intell Syst Mol Biol. 1995;3:215-21
pubmed: 7584440
J Mol Biol. 1994 Nov 4;243(4):574-8
pubmed: 7966282
Bioinformatics. 1998;14(9):755-63
pubmed: 9918945

Auteurs

Zonglin He (Z)

Vaccine and Infectious Disease Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Youyi Fong (Y)

Vaccine and Infectious Disease Division and Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Department of Biostatistics, University of Washington, Seattle, Washington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH